FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

The Harvard Drug Group Quetiapine Fumarate Extended-Release Tablets Recall

Quetiapine Fumarate Extended-Release Tablets, 50 mg, 100 tablets per unit dose carton,…

The Harvard Drug Group · Livonia, MI

Risk level
Class III
Reported by FDA
Mar 18, 2020
Recall ID
D-0999-2020
Check your lot numberHow we source this data

Summary

The Harvard Drug Group recalled Quetiapine Fumarate Extended-Release Tablets starting Feb 27, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0999-2020 on Mar 18, 2020. Reason: Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets. Status: Terminated.

Why it was recalled

Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.

Product description

Quetiapine Fumarate Extended-Release Tablets, 50 mg, 100 tablets per unit dose carton, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454775 India; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA. NDC: 0904-6801-61

Lot numbers, UPCs & expiration codes

Lot, expiry: Lot N00028, exp 04/2021; Lot N00044, exp 06/2021

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0999-2020
Classification
Class III
Status
Terminated
Recall initiated
Feb 27, 2020
FDA report date
Mar 18, 2020
Quantity
330 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
The Harvard Drug Group

Original FDA data

Every field from FDA enforcement report D-0999-2020, exactly as published.

Show all FDA fields
City
Livonia
State
MI
Status
Terminated
Country
United States
Event ID
85138
Address
17177 N Laurel Park Dr Ste 233
Code information
Lot, expiry: Lot N00028, exp 04/2021; Lot N00044, exp 06/2021
Postal code
48152-3951
Report date
Mar 18, 2020
Product type
Drugs
Recall number
D-0999-2020
Classification
Class III
Recalling firm
The Harvard Drug Group
Product quantity
330 cartons
Termination date
Sep 24, 2022
Reason for recall
Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Quetiapine Fumarate Extended-Release Tablets, 50 mg, 100 tablets per unit dose carton, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454775 India; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA. NDC: 0904-6801-61
Distribution pattern
Nationwide
Recall initiation date
Feb 27, 2020
Initial firm notification
Letter
Center classification date
Mar 11, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0999-2020, published Mar 18, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls